Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples